A computational model of fibroblast growth factor-2 binding to endothelial cells under fluid flow

Annals of Biomedical Engineering

Volumn 41, Issue 1, 2013, Pages 154-171

  Patel, Nisha S ^a   Reisig, Karl V ^a   Clyne, Alisa Morss ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

Convective mass transport; Endothelial cells; FGF 2 binding kinetics; Fluid flow; Triad formation

Indexed keywords

ANGIOGENESIS; ANGIOGENIC GROWTH FACTORS; BASEMENT MEMBRANE; BINDING KINETICS; BINDING SITE MODELS; CELL SURFACE RECEPTORS; COMPLEX FORMATIONS; COMPLEX STABILITY; COMPUTATIONAL MODEL; DELIVERY MODES; DISSOCIATION RATE CONSTANT; FIBROBLAST GROWTH FACTOR-2; FLOW EFFECTS; HEPARAN SULFATES; INTEGRATED EFFECTS; PHYSIOLOGICAL CONDITION; PHYSIOLOGICAL FLUIDS; PROTEOGLYCANS; TRIAD FORMATION;

BINDING SITES; CELL MEMBRANES; COMPUTATIONAL METHODS; DISSOCIATION; ENDOTHELIAL CELLS; FLOW OF FLUIDS; FLOW RATE; PHYSIOLOGY; RATE CONSTANTS; STOICHIOMETRY;

PHYSIOLOGICAL MODELS;

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEOHEPARAN SULFATE;

ANIMAL; ARTICLE; BINDING SITE; BIOLOGICAL MODEL; CELL CULTURE; CELL STRAIN 3T3; ENDOTHELIUM CELL; KINETICS; METABOLISM; MOUSE; REPRODUCIBILITY; SWINE;

ANIMALS; BALB 3T3 CELLS; BINDING SITES; CELLS, CULTURED; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE PROTEOGLYCANS; KINETICS; MICE; MODELS, BIOLOGICAL; RECEPTORS, FIBROBLAST GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; SWINE;

EID: 84871630787     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-012-0622-4     Document Type: Article

References (48)

1. Alon, R., D. A. Hammer, and T. A. Springer. Lifetime of the P-selectin-carbohydrate bond and its response to tensile force in hydrodynamic flow. Nature 374(6522):539-542, 1995.
2. Bacabac, R. G., T. H. Smit, S. C. Cowin, J. J. Van Loon, F. T. Nieuwstadt, R. Heethaar, and J. Klein-Nulend. Dynamic shear stress in parallel-plate flow chambers. J. Biomech. 38(1):159-167, 2005. (Pubitemid 39424990)
3. Beenken, A., and M. Mohammadi. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8(3):235-253, 2009.
4. Bikfalvi, A., S. Klein, G. Pintucci, and D. B. Rifkin. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18(1):26-45, 1997. (Pubitemid 27076454)
5. Brower, J. B., J. H. Targovnik, M. R. Caplan, and S. P. Massia. High glucose-mediated loss of cell surface heparan sulfate proteoglycan impairs the endothelial shear stress response. Cytoskeleton (Hoboken) 67(3):135-141, 2010.
6. Burgess, W. H., and T. Maciag. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58:575-606, 1989. (Pubitemid 19172981)
7. Chen, S., and T. A. Springer. Selectin receptor-ligand bonds: formation limited by shear rate and dissociation governed by the Bell model. Proc. Natl Acad. Sci. USA. 98(3):950-955, 2001. (Pubitemid 32121168)
8. Chua, C. C., N. Rahimi, K. Forsten-Williams, and M. A. Nugent. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ. Res. 94(3):316-323, 2004. (Pubitemid 38240722)
9. Clyne, A. M., and E. R. Edelman. Vascular growth factor binding kinetics to the endothelial cell basement membrane, with a kinetics-based correction for substrate binding. Cytotechnology 60:33-44, 2009.
10. Doggett, T. A., G. Girdhar, A. Lawshe, D. W. Schmidtke, I. J. Laurenzi, S. L. Diamond, and T. G. Diacovo. Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIb(alpha)-vWF tether bond. Biophys. J. 83(1):194-205, 2002. (Pubitemid 34694731)
11. Dowd, C. J., C. L. Cooney, and M. A. Nugent. Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J. Biol. Chem. 274(8):5236-5244, 1999. (Pubitemid 29113434)
12. Faham, S., R. E. Hileman, J. R. Fromm, R. J. Linhardt, and D. C. Rees. Heparin structure and interactions with basic fibroblast growth factor. Science 271(5252):1116-1120, 1996. (Pubitemid 26075225)
13. Fannon, M., K. Forsten-Williams, C. J. Dowd, D. A. Freedman, J. Folkman, and M. A. Nugent. Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment. FASEB J. 17(8):902-904, 2003.
14. Fannon, M., and M. A. Nugent. Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate. J. Biol. Chem. 271(30):17949-17956, 1996. (Pubitemid 26250777)
15. Filion, R. J., and A. S. Popel. A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors. Ann. Biomed. Eng. 32(5):645-663, 2004.
16. Finger, E. B., K. D. Puri, R. Alon, M. B. Lawrence, U. H. von Andrian, and T. A. Springer. Adhesion through L-selectin requires a threshold hydrodynamic shear. Nature 379(6562):266-269, 1996.
17. Folkman, J., M. Klagsbrun, J. Sasse, M. Wadzinski, D. Ingber, and I. Vlodavsky. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am. J. Pathol. 130(2):393-400, 1988. (Pubitemid 18076374)
18. Forsten, K. E., M. Fannon, and M. A. Nugent. Potential mechanisms for the regulation of growth factor binding by heparin. J. Theor. Biol. 205(2):215-230, 2000. (Pubitemid 30662921)
19. Forsten-Williams, K., C. C. Chua, and M. A. Nugent. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling. J. Theor. Biol. 233(4):483-499, 2005. (Pubitemid 40320595)
20. Fuki, I. I., R. V. Iozzo, and K. J. Williams. Perlecan heparan sulfate proteoglycan. A novel receptor that mediates a distinct pathway for ligand catabolism. J. Biol. Chem. 275(40):31554, 2000.
21. Gajdusek, C., P. DiCorleto, R. Ross, and S. M. Schwartz. An endothelial cell-derived growth factor. J. Cell Biol. 85(2):467-472, 1980. (Pubitemid 10032016)
22. Han, J., F. Zhang, J. Xie, R. J. Linhardt, and L. M. Hiebert. Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin. Cardiovasc. Diabetol. 8:46, 2009.
23. Harada, K., W. Grossman, M. Friedman, E. R. Edelman, P. V. Prasad, C. S. Keighley, W. J. Manning, F. W. Sellke, and M. Simons. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Investig. 94(2):623-630, 1994. (Pubitemid 24250992)
24. Ibrahimi, O. A., F. Zhang, S. C. Hrstka, M. Mohammadi, and R. J. Linhardt. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry 43(16):4724-4730, 2004. (Pubitemid 38509093)
25. Kan, M., F. Wang, J. Xu, J. W. Crabb, J. Hou, and W. L. McKeehan. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259(5103):1918-1921, 1993. (Pubitemid 23124467)
26. Lazarous, D. F., E. F. Unger, S. E. Epstein, A. Stine, J. L. Arevalo, E. Y. Chew, and A. A. Quyyumi. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J. Am. Coll. Cardiol. 36(4):1239-1244, 2000.
27. Lederman, R. J., F. O. Mendelsohn, R. D. Anderson, J. F. Saucedo, A. N. Tenaglia, J. B. Hermiller, W. B. Hillegass, K. Rocha-Singh, T. E. Moon, M. J. Whitehouse, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359(9323):2053-2058, 2002. (Pubitemid 34680967)
28. Lin, X., E. M. Buff, N. Perrimon, and A. M. Michelson. Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126(17):3715-3723, 1999. (Pubitemid 29440471)
29. Montesano, R., J. D. Vassalli, A. Baird, R. Guillemin, and L. Orci. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl Acad. Sci. USA. 83(19):7297-7301, 1986. (Pubitemid 16000508)
30. Moscatelli, D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol. 131(1):123-130, 1987. (Pubitemid 17067272)
31. Neufeld, G., and D. Gospodarowicz. The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J. Biol. Chem. 260(25):13860-13868, 1985. (Pubitemid 16233246)
32. Nugent, M. A., and E. R. Edelman. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. Biochemistry 31(37):8876-8883, 1992.
33. Nugent, M. A., and R. V. Iozzo. Fibroblast growth factor-2. Int. J. Biochem. Cell Biol. 32(2):115-120, 2000. (Pubitemid 30001815)
34. Pellegrini, L. Role of heparan sulfate in fibroblast growth factor signalling: a structural view. Curr. Opin. Struct. Biol. 11(5):629-634, 2001. (Pubitemid 32972028)
35. Quarto, N., and F. Amalric. Heparan-sulfate proteoglycans as transducers of Fgf-2 signaling. J. Cell Sci. 107:3201-3212, 1994. (Pubitemid 24365224)
36. Reisig, K., and A. M. Clyne. Fibroblast growth factor-2 binding to the endothelial basement membrane peaks at a physiologically relevant shear stress. Matrix Biol. 29(7):586-593, 2010.
37. Roghani, M., A. Mansukhani, P. Dell'Era, P. Bellosta, C. Basilico, D. B. Rifkin, and D. Moscatelli. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269(6):3976-3984, 1994. (Pubitemid 24237743)
38. Ruel, M., R. J. Laham, J. A. Parker, M. J. Post, J. A. Ware, M. Simons, and F. W. Sellke. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J. Thorac. Cardiovasc. Surg. 124(1):28-34, 2002.
39. Safran, M., M. Eisenstein, D. Aviezer, and A. Yayon. Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2. Biochem. J. 345(Pt 1):107-113, 2000. (Pubitemid 30060110)
40. Shen, W., C. Zhang, M. W. Fannon, K. Forsten-Williams, and J. Zhang. A computational model of FGF-2 binding and HSPG regulation under flow. IEEE Trans. Biomed. Eng. 56(9):2147-2155, 2009.
41. Sherwood, L. Cengage Learning (Firm). Human physiology: from cells to systems, 7th ed. Australia; United States: Brooks/Cole, Cengage Learning, 2010.
42. Simons, M., B. H. Annex, R. J. Laham, N. Kleiman, T. Henry, H. Dauerman, J. E. Udelson, E. V. Gervino, M. Pike, M. J. Whitehouse, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105(7):788-793; 2002. (Pubitemid 34174916)
43. Smith, S. M., L. A. West, P. Govindraj, X. Zhang, D. M. Ornitz, and J. R. Hassell. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors. Matrix Biol. 26(3):175-184, 2007. (Pubitemid 46401230)
44. Unger, E. F., L. Goncalves, S. E. Epstein, E. Y. Chew, C. B. Trapnell, R. O. Cannon III, and A. A. Quyyumi. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am. J. Cardiol. 85(12):1414-1419, 2000. (Pubitemid 30336575)
45. Vlodavsky, I., J. Folkman, R. Sullivan, R. Fridman, R. Ishai-Michaeli, J. Sasse, and M. Klagsbrun. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Natl Acad. Sci. USA. 84(8):2292-2296, 1987. (Pubitemid 17075857)
46. Yayon, A., M. Klagsbrun, J. D. Esko, P. Leder, and D. M. Ornitz. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64(4):841-848, 1991. (Pubitemid 121001170)
47. Zhang, Z., C. Coomans, and G. David. Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model. J. Biol. Chem. 276(45):41921-41929, 2001. (Pubitemid 37371091)
48. Zhao, B., C. Zhang, K. Forsten-Williams, J. Zhang, and M. Fannon. Endothelial cell capture of heparin-binding growth factors under flow. PLoS Comput. Biol. 6(10):e1000971, 2010.